Holdings
VIP Health Care Portfolio
As of Jun 30, 2026, VIP Health Care Portfolio reported 100 positions worth US$1.1B. Largest: Eli Lilly And Company, Danaher Corporation and Thermo Fisher Scientific Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Eli Lilly And Company | 75,000 | US$90M | +2,200 | Jun 30, 2026 |
| Danaher Corporation | 390K | US$74.3M | +30,000 | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 116K | US$58.2M | +79,200 | Jun 30, 2026 |
| Johnson & Johnson | 208K | US$52.8M | −34,800 | Jun 30, 2026 |
| Unitedhealth Group Incorporated | 108K | US$44.9M | +61,500 | Jun 30, 2026 |
| Abbvie Inc. | 128K | US$32.2M | −39,000 | Jun 30, 2026 |
| Ascendis Pharma A/s | 100K | US$26.7M | −10,000 | Jun 30, 2026 |
| Alnylam Pharmaceuticals, Inc. | 75,400 | US$22.7M | +15,400 | Jun 30, 2026 |
| Merck & Company, Inc. | 170K | US$21.8M | −40,000 | Jun 30, 2026 |
| Argenx Se | 22,040 | US$20.4M | −4,760 | Jun 30, 2026 |